Microbiome drives pancreatic inflammation and tumorigenesis
The gut and intratumoral microbiome are significant risk factors for pancreatic inflammation and tumorigenesis.
The microbiome has the potential to translocate from the gastrointestinal tract to the pancreas in the context of dysbiosis.
Microbial components or metabolites modulate the host immune response.
Targeting a specific microbiome might significantly enhance patients’ responses to anticancer therapy.
https://www.cell.com/trends/cancer/fulltext/S2405-8033(26)00081-6
